Potential benefits of rapid genetic testing for germline WT1 in infants with bilateral renal tumors: A case report

Pediatr Blood Cancer. 2022 Feb;69(2):e29368. doi: 10.1002/pbc.29368. Epub 2021 Sep 24.

Authors

Haruna Yoshikawa¹, Takeshi Sato^{1

2}, Takahiro Ishikawa¹, Jumpei Ito¹, Fumito Yamazaki¹, Haruko Shima¹, Misa Honda^{1

2}, Hironori Shibata^{1

2}, Tomohiro Ishii^{1

2}, Hiroshi Asanuma^{2

3}, Hiroyuki Shimada¹, Tomonobu Hasegawa^{1

2}

Affiliations

¹ Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.
² The Center for Differences of Sex Development, Keio University Hospital, Tokyo, Japan.
³ Department of Urology, Keio University School of Medicine, Tokyo, Japan.

PMID: 34558169
DOI: 10.1002/pbc.29368

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Female
Genetic Testing
Germ Cells
Humans
Infant
Kidney Neoplasms* / genetics
Male
WT1 Proteins / genetics
Wilms Tumor* / genetics

Substances

WT1 Proteins
WT1 protein, human